• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITHS MEDICAL ASD, INC. CLEO® 90 INFUSION SET; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITHS MEDICAL ASD, INC. CLEO® 90 INFUSION SET; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Device Problems Break (1069); Detachment Of Device Component (1104)
Patient Problems Hyperglycemia (1905); Device Embedded In Tissue or Plaque (3165)
Event Type  Injury  
Manufacturer Narrative
Date of event: the patient reported "about a year ago".Customer has not returned the device to the manufacturer for device evaluation.If the device becomes available and is returned and evaluated, the manufacturer will file a follow-up report detailing the results of the evaluation.(b)(4).
 
Event Description
It was reported that a cleo® 90 infusion set had broken off and detached inside the patient's body under his skin.The site was located at either the patient's buttock or the inner thigh of the patient's left leg.The patient's blood sugar levels rose as high as 400mg/dl due to the event; the blood sugars were typically kept at 110mg/dl.The patient noted that he was very active and very lean and wore loose fitting jeans that do not tug on the device.The infusion set was either replaced with a new set or an injection was used to bring down the blood sugar levels.No permanent injury was reported.See mfr: 3012307300-2016-00545 and 3012307300-2016-00546.
 
Manufacturer Narrative
One used cleo® 90 infusion set was returned for investigation.Visual inspection revealed of the returned site found that the soft cannula had separated approximately 2mm from the base; the remaining length of cannula was not returned.Upon further examination, no other defects were found with the device; the wall thickness of the cannula and the site crown appeared as intended.Investigation was unable to determine the root cause of the cannula separation; however, no evidence was found to suggest an intrinsic defect in the site.
 
Manufacturer Narrative
Please note: the patient reported that they weigh between (b)(6).The patient reported that the events have occurred over the "last 2 years" and the exact event dates are unknown.Age/date of birth, weight, date of event, describe event or problem - additional information.
 
Event Description
Additional information was received regarding the reported incident.The patient reported the cannula of the cleo 90 infusion set detached from the site and remained in the patient skin.The patient reported that they attempted to remove the cannula from their body; however, they were unable to.The patient stated that they spoke to their endocrinologist regarding the reported incident.It was reported that the patient did not receive any additional medical treatment due to the reported event.According to the patient the incident was unresolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLEO® 90 INFUSION SET
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
SMITHS MEDICAL ASD, INC.
6000 nathan lane north
minneapolis MN 55442
Manufacturer (Section G)
SMITHS HEALTHCARE MFG
s.a. de c.v. ave calidad no. 4
parque industrial internaciona
tijuana, b.c. 22425
MX   22425
Manufacturer Contact
lisa perz
6000 nathan lane north
minneapolis, MN 55442
7633833074
MDR Report Key6167362
MDR Text Key62185151
Report Number3012307300-2016-00543
Device Sequence Number1
Product Code FPA
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K042172
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Patient
Type of Report Initial,Followup,Followup,Followup
Report Date 05/11/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/12/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/29/2016
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Date Manufacturer Received12/14/2016
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-